Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to regulation 30 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we are enclosing herewith copies of newspaper publication of extract of financial results of the Company for the quarter and financial year ended 31 March 2023, published in Financial Express (English edition) and Vadodara Samachar (Gujarati edition) on 06 May 2023. The above information shall be made available on the website of the Company at www.tatvachintan.com.
06-05-2023
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Earnings Call Recording

 Pursuant to Regulation 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we hereby inform the exchanges that the recording of the Earnings Call held on Friday, 05 May 2023 at 05:00 p.m. IST is available on the website of the Company. The recording can be accessed from the following link: https://www.tatvachintan.com/wp-content/uploads/2023/05/ICI3420230505146652.mp3 The above information is available on the website of the Company at www.tatvachintan.com.
05-05-2023
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions in the format specified under SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated 22 November 2021, for the half year ended 31 March 2023. The above information shall be made available on the website of the Company at www.tatvachintan.com.
05-05-2023

Tatva Chintan Pharma Chem Results Earnings Call for Q4FY23

 Conference Call with Tatva Chintan Pharma Chem Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript.
05-05-2023
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed a copy of the Press Release on financial results of the Company for the quarter and financial year ended 31 March 2023. The above information shall be made available on the website of the Company at www.tatvachintan.com.
05-05-2023
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed Investor Presentation for the quarter and financial year ended 31 March 2023. The above information shall be made available on the website of the Company at www.tatvachintan.com.
05-05-2023
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Dividend Updates

 The Board Recommended a Final Dividend of Rs. 2/- (20%) per equity share of Rs. 10/- each fully paid (subject to deduction of tax, if any) on the equity share capital of Rs. 22,16,50,620/- (2,21,65,062 equity shares of Rs. 10/- each) for the financial year 2022-23. This shall be paid subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.
05-05-2023
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

 Based on the recommendation made by the Audit Committee, the Board of Directors of the Company recommended the re-appointment of M/s NDJ & Co., (Firm Registration No.: 136345W), Chartered Accountants, Surat, as the Statutory Auditors of the Company for a second term of 5 (five) consecutive years from the conclusion of the ensuing 27th Annual General Meeting of the Company till the conclusion of the 32nd Annual General Meeting of the Company to be held in the year 2028, subject to the approval of the shareholders of the Company.
05-05-2023
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Corporate Action-Board approves Dividend

 The Board Recommended a Final Dividend of Rs. 2/- (20%) per equity share of Rs. 10/- each fully paid (subject to deduction of tax, if any) on the equity share capital of Rs. 22,16,50,620/- (2,21,65,062 equity shares of Rs. 10/- each) for the financial year 2022-23. This shall be paid subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.
05-05-2023
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Financial Year Ended On 31 March 2023

 Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter and Financial Year Ended On 31 March 2023
05-05-2023
Next Page
Close

Let's Open Free Demat Account